CN101889005B - 玉米赤霉烯酮大环内酯类似物合成过程中的中间物 - Google Patents

玉米赤霉烯酮大环内酯类似物合成过程中的中间物 Download PDF

Info

Publication number
CN101889005B
CN101889005B CN200880119543.8A CN200880119543A CN101889005B CN 101889005 B CN101889005 B CN 101889005B CN 200880119543 A CN200880119543 A CN 200880119543A CN 101889005 B CN101889005 B CN 101889005B
Authority
CN
China
Prior art keywords
formula
compound
hydrogen
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200880119543.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN101889005A (zh
Inventor
弗兰西斯·G·方
牛祥
马修·J·施纳德尔贝克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of CN101889005A publication Critical patent/CN101889005A/zh
Application granted granted Critical
Publication of CN101889005B publication Critical patent/CN101889005B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
CN200880119543.8A 2007-12-07 2008-12-08 玉米赤霉烯酮大环内酯类似物合成过程中的中间物 Active CN101889005B (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US1240807P 2007-12-07 2007-12-07
US1241107P 2007-12-07 2007-12-07
US1240907P 2007-12-07 2007-12-07
US61/012,411 2007-12-07
US61/012,408 2007-12-07
US61/012,409 2007-12-07
US8004808P 2008-07-11 2008-07-11
US61/080,048 2008-07-11
PCT/US2008/013512 WO2009075823A1 (en) 2007-12-07 2008-12-08 Intermediates in the synthesis of zearalenone macrolide analogs

Publications (2)

Publication Number Publication Date
CN101889005A CN101889005A (zh) 2010-11-17
CN101889005B true CN101889005B (zh) 2015-06-03

Family

ID=40445478

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2008801195442A Active CN101889006B (zh) 2007-12-07 2008-12-08 用于制备玉米赤霉烯酮大环内酯类似物的中间物和方法
CN200880119543.8A Active CN101889005B (zh) 2007-12-07 2008-12-08 玉米赤霉烯酮大环内酯类似物合成过程中的中间物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN2008801195442A Active CN101889006B (zh) 2007-12-07 2008-12-08 用于制备玉米赤霉烯酮大环内酯类似物的中间物和方法

Country Status (10)

Country Link
US (3) US8507696B2 (enExample)
EP (2) EP2231634B1 (enExample)
JP (3) JP5496908B2 (enExample)
CN (2) CN101889006B (enExample)
BR (2) BRPI0820958B1 (enExample)
CA (2) CA2708141C (enExample)
IL (2) IL205954A (enExample)
MX (2) MX2010006091A (enExample)
RU (2) RU2478630C2 (enExample)
WO (2) WO2009075823A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478065C (en) 2002-03-08 2013-01-08 Eisai Co. Ltd. Macrocyclic compounds useful as pharmaceuticals
CN105748465A (zh) 2007-07-25 2016-07-13 卫材R&D管理株式会社 用于治疗癌症的多激酶抑制剂
CA2708141C (en) * 2007-12-07 2016-07-05 Eisai R & D Management Co., Ltd. Intermediates and methods for making zearalenone macrolide analogs

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1653059A (zh) * 2002-03-08 2005-08-10 卫材株式会社 用作医药品的大环化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69666A (en) * 1982-09-13 1987-10-20 Lilly Co Eli 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use
GB9225396D0 (en) 1992-12-04 1993-01-27 Sandoz Ltd Improvements in or relating to organic compounds
US5795910A (en) 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
SK286592B6 (sk) * 1997-07-08 2009-01-07 Bristol-Myers Squibb Company Derivát epotilónu, farmaceutický prostriedok s jeho obsahom a jeho použitie
JP2004292314A (ja) 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤
JP2004292315A (ja) 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd Ｔａｋ１阻害剤
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
US8067412B2 (en) 2006-08-11 2011-11-29 Universite De Strasbourg Macrocyclic compounds useful as inhibitors of kinases and HSP90
US8513440B2 (en) * 2007-06-05 2013-08-20 Universite De Strasbourg Compositions and methods comprising analogues of radicicol A
CN105748465A (zh) 2007-07-25 2016-07-13 卫材R&D管理株式会社 用于治疗癌症的多激酶抑制剂
TW200924749A (en) * 2007-07-25 2009-06-16 Eisai R & Amp D Man Co Ltd Zearalenone macrolide derivatives and uses of the same
CA2708141C (en) * 2007-12-07 2016-07-05 Eisai R & D Management Co., Ltd. Intermediates and methods for making zearalenone macrolide analogs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1653059A (zh) * 2002-03-08 2005-08-10 卫材株式会社 用作医药品的大环化合物
US20060247448A1 (en) * 2002-03-08 2006-11-02 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Fast and efficient synthesis of the complete LL-Z1640-2 framework;Neil Henry et al.;《Tetrahedron Letters》;20070704;第48卷;第6088-6091页 *

Also Published As

Publication number Publication date
CA2708143A1 (en) 2009-06-18
JP5496908B2 (ja) 2014-05-21
IL205983A (en) 2017-01-31
US20110237805A1 (en) 2011-09-29
BRPI0820953B1 (pt) 2022-04-05
BRPI0820953A2 (pt) 2015-06-23
JP2014141498A (ja) 2014-08-07
RU2497803C2 (ru) 2013-11-10
MX2010005999A (es) 2010-06-23
EP2231635A1 (en) 2010-09-29
EP2231634B1 (en) 2016-05-11
IL205954A0 (en) 2010-11-30
CN101889006A (zh) 2010-11-17
CA2708141A1 (en) 2009-06-18
EP2231635B1 (en) 2014-03-19
IL205954A (en) 2017-01-31
JP2011506323A (ja) 2011-03-03
JP5492786B2 (ja) 2014-05-14
WO2009075823A1 (en) 2009-06-18
CN101889005A (zh) 2010-11-17
WO2009075818A1 (en) 2009-06-18
RU2010128096A (ru) 2012-01-20
CA2708141C (en) 2016-07-05
US20110046398A1 (en) 2011-02-24
BRPI0820958A2 (pt) 2015-07-07
US20130211103A1 (en) 2013-08-15
MX2010006091A (es) 2010-06-25
JP2011506324A (ja) 2011-03-03
EP2231634A1 (en) 2010-09-29
CN101889006B (zh) 2013-09-04
IL205983A0 (en) 2010-11-30
BRPI0820958B1 (pt) 2022-04-05
RU2010128103A (ru) 2012-01-20
US8350059B2 (en) 2013-01-08
US8507696B2 (en) 2013-08-13
CA2708143C (en) 2016-10-11
RU2478630C2 (ru) 2013-04-10

Similar Documents

Publication Publication Date Title
JP7285838B2 (ja) アンドロゲン受容体拮抗薬として使用されるジアリールチオヒダントイン化合物
TW201130841A (en) Process for preparing entecavir and its intermediates
CA3222540A1 (en) Process for preparing an erk inhibitor
KR101545068B1 (ko) Ｃｄｄｏ 에틸 에스테르의 다형체 및 이의 용도
CN101889005B (zh) 玉米赤霉烯酮大环内酯类似物合成过程中的中间物
CN104650109B (zh) 紫杉烷类化合物
EP3915977A1 (en) 1,2,3,4-tetrahydroquinoxaline derivative, preparation method therefor and application thereof
CN117447460A (zh) 作为ripk1抑制剂的杂环化合物
EP4089090A1 (en) Method for preparing coumarin compound, 3 position of which is substituted with amidoalkyl and products and related intermediates thereof
WO2006040644A2 (en) Processes for the preparation of substituted thiochroman derivatives
US6071945A (en) 8H-thieno-[2,3-b]pyrrolizin-8-one compounds
CN104650012A (zh) 一种紫杉烷类化合物
WO2025245089A1 (en) Processes for preparing tetralin compounds
JP2023141142A (ja) シクロアルカン－１，３－ジアミン誘導体の結晶及びその製造方法
KR20250174969A (ko) 올리고뉴클레오티드 유사체 또는 이의 염을 제조하기 위한 중간체 및 이의 제조 방법
JPH0121143B2 (enExample)
HK1013820A1 (en) Crystalline form of dihydro-2,3-benzodiazepine derivative
HK1013819A1 (en) Physical form of dihidro-2,3-benzodiazepine derivative
HK1013820B (en) Crystalline form of dihydro-2,3-benzodiazepine derivative

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant